[Anticoagulants in the prevention of complications in patients with atrial fibrillation].
Skibitskiĭ Vv, Kanorskií Sg
Abstract
Skibitskiĭ Vv, Kanorskií Sg
Abstract
This review presents new data on the comparative effectiveness and safety of treatment with oral anticoagulants warfarin, dabigatran, rivaroxaban, apixaban for prevention of thromboembolism in patients with atrial fibrillation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This review presents new data on the comparative effectiveness and safety of treatment with oral anticoagulants warfarin, dabigatran, rivaroxaban, apixaban for prevention of thromboembolism in patients with atrial fibrillation.
Key concepts: Atrial fibrillation, Cardiology, Medicine, Internal medicine